ArticleeLife2025

Immunogenicity and safety of a live-attenuated SARS-CoV-2 vaccine candidate based on multiple attenuation mechanisms.

Mie Suzuki Okutani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.